SV Life Sciences expands team with new hires

SV Life Sciences has hired Dan Burgess, Dr. Ed Mascioli and Dr. Michael Mendelsohn as new venture partners. Burgess was the founder, president and CEO of Rempex Pharmaceuticals while Mascioli was the CEO of Affinium Pharmaceuticals. And, previously, Mendelsohn worked at Merck Research Laboratories where he served as senior vice president and global franchise head, cardiovascular diseases.

PanOptica snags $45 mln Series B funds

PanOptica said Tuesday that it has closed up to $45 million in Series B funding. Novo Ventures and Third Rock Ventures led the round with participation from SV Life Sciences. Headquartered in Bernardsville, NJ, PanOptica is a biopharmaceutical firm focused on ophthalmology therapies.


ICON agrees to acquire PE-backed Aptiv Solutions for $143.5 mln

ICON has agreed to buy Aptiv Solutions for a cash consideration of $143.5 million. The sellers are The Halifax Group, SV Life Sciences, Comvest Partners and Aptiv’s management. Headquartered in Reston, Virginia, Aptiv Solutions is a biopharmaceutical and medical device company.

Edmond de Rothschild Investment Partners Backs OncoEthix Series B

Edmond de Rothschild Investment Partners has backed the Series B financing round of OncoEthix through BioDiscovery 4, its fourth fund dedicated to life sciences. OncoEthix is a Swiss-based oncology drug development company founded in 2009. Edmond de Rothschild Investment Partners participated alongside SV Life Sciences and existing investors Index Ventures and Endeavour Vision.

Cibiem Appoints President and CEO

Medical device company Cibiem has appointed Ken Martin to president and chief executive officer. Martin will succeed Cibiem co-founder Howard R. Levin who will continue his active involvement within the company and as a member of its board of directors.The company is backed by SV Life Sciences and Third Rock Ventures.

SV Life Sciences Makes Black a Managing Partner

SV Life Sciences said Monday that Darren Black was named a managing partner while Tom Flynn was made a partner. Black joined SV Life Sciences in 2003 and will continue to focus on healthcare services, pharmaceutical services and healthcare information technology. Flynn joined the life sciences VC firm in 2011 and targets post-acute care delivery and healthcare information technology services.

SV Life Sciences, Bessemer Back Post-Acutre Care Provider Health Essentials

Health Essentials, a provider of post-acute care management services, has raised an undisclosed amount of funding from SV Life Sciences and Bessemer Venture Partners. Health Essentials, which provides care to the frail and elderly population in California, Nevada and Arizona, aims to use the growth funding to expand into new geographies. As part of the funding, Stephen Kraus from Bessemer and Tom Flynn from SV Life Sciences, have joined the board.

Sutro Biopharma Secures More Funds Led by Skyline Ventures

San Francisco-based Sutro Biopharma has closed a $16.5 million second tranche of its Series C financing. The financing was led by Skyline Ventures and included participation of Lilly Ventures, Amgen Ventures, SV Life Sciences and Alta Partners. Sutro has raised almost $60 million since its founding in 2003. PRESS RELEASE Sutro Biopharma today announced the […]

CardioKinetix Appoints Veteran Medical Device Exec

Medical device company CardioKinetix has apointed Maria Sainz as president and chief executive officer. Recently Sainz served as general manager of Stryker Neurovascular, which acquired Concentric Medical in October 2011 under her leadership as president and CEO. CardioKinetix is backed by SV Life Sciences, New Leaf Venture Partners, U.S. Venture Partners, Panorama Capital, and H&Q […]

SV Life Sciences, Petra Captial Provide Funding to WellNow Urgent Care

WellNow Urgent Care has lauched with $35 million in committed capital from investors including SV Life Sciences, Petra Capital Partners and River Cities Capital Funds. Nashville, Tenn-based WellNow focuses on treating patients in underserved markets. PRESS RELEASE WellNow Urgent Care, a new urgent care company focused on treating patients in underserved markets, has launched operations […]

TransEnterix Closes $15 million Round

TransEnterix Inc. has closed a $15 million in venture capital financing. TransEnterix currently markets throughout Europe and the US a platform called the SPIDER® Surgical System. The funding is the second tranche of the company’s Series B financing secured in 2009. Aisling Capital, Quaker BioVentures, Intersouth Partners, Synergy Life Science Partners and SV Life Sciences […]

Catabasis Pharma Bags $8M More for Series A

Massachusetts-based Catabasis Pharmaceuticals raised an additional $8 million in its Series A financing, now bringing its total funding for the round to $47.6 million. The company is developing an omega-3 conjugated compound for patients with severe hypertriglyceridemia. SV Life Sciences, Clarus Ventures, MedImmune Ventures and Advanced Technology Ventures all participated in the funding.

topiVert Attracts Start-up Funding

Imperial Innovations Group, a technology commercialisation and investment group, and SV Life Sciences have committed to invest 8 million pounds ($12.52 million) in new start-up company TopiVert. The start-up will focus on developing topical medicines for inflammatory diseases of the eye and gut. PRESS RELEASE Imperial Innovations Group plc (AIM: IVO, ‘Innovations’), a leading technology […]

AcuFocus Inks $65 Million

AcuFocus a maker of corneal inlay, has closed a $65 million financing round led by Cowen Healthcare Royalty Partners. Existing investors SV Life Sciences, Versant Ventures, Carlyle Group, Accuitive Medical Ventures and Bausch & Lomb participated, with Medtronic also joining in the round. Cowen Royalty’s $30 million investment included a $25 million Synthetic Royalty(SM) investment […]

Imagen Biotech Closes $40 Mln In Financing

Imagen Biotech said Wednesday that it has received up to $40 million in Series A financing from SV Life Sciences, Novo Ventures, and Fidelity Biosciences. Imagen Biotech is developing treatments to treat blinding diseases like dry AMD.

SVLS Recruits Venture Partner

SV Life Sciences (SVLS) has appointed Dr. Heiner Dreismann as venture partner. Dr. Dreismann joins SVLS with more than 26 years of experience in the health care industry.

CardioKinetix Seals $44M For Medical Devices

CardioKinetix, a medical device company developing transcatheter implants, has raised $44 million in a two-tranche Series E financing. New investors SV Life Sciences and New Leaf Venture Partners led the round, which included return backers including U.S. Venture Partners, J.P. Morgan Partners, H&Q Healthcare Investors and H&Q Life Sciences Investors. The company’s device, dubbed Parachute, is implanted into the left ventricle of the heart in a simple catheter lab procedure and is intended to treat patients with heart failure resulting from a myocardial infarction or heart attack.

PEHUB Community

Join the 12504 members of peHUB to make connections, share your opinion, and follow your favorite authors.

Join the Community

Look Who’s Tweeting

PE HUB News Briefs

RSS Feed Widget

VCJ Headlines (subscribers only)

RSS Feed Widget

Buyouts Headlines (subscribers only)

RSS Feed Widget

Reuters VC and PE feed

RSS Feed Widget